STOCK TITAN

Nevro to Present at 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Nevro Corp. (NYSE: NVRO), a leader in innovative medical devices for chronic pain, announced its participation in the 40th Annual J.P. Morgan Healthcare Conference. D. Keith Grossman, Chairman, CEO, and President, will present on January 10, 2022, at 7:30 am PT in San Francisco, CA. A live webcast will be accessible on Nevro's website. The company focuses on the Senza spinal cord stimulation system, which offers evidence-based, non-pharmacologic pain management solutions.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., Dec. 10, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 7:30 am Pacific Time / 10:30 am Eastern Time at the Westin St. Francis Hotel in San Francisco, CA.

A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro's website at www.nevro.com

Internet Posting of Information

Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at www.nevro.com.  The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy. Senza, Senza II, Senza Omnia, HFX, HXF Coach, HFX Cloud, HFX Connect, Nevro and the Nevro logo are trademarks of Nevro Corp.

To learn more about Nevro, connect with us on LinkedIn, Twitter, Facebook and Instagram.

Investors and Media:
Julie Dewey, IRC
Nevro Corp.
Vice President, Investor Relations & Corp Communications
650-433-3247  |  julie.dewey@nevro.com

.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nevro-to-present-at-40th-annual-jp-morgan-healthcare-conference-301442029.html

SOURCE Nevro Corp.

FAQ

When will Nevro present at the J.P. Morgan Healthcare Conference?

Nevro will present on January 10, 2022, at 7:30 am Pacific Time.

Who will represent Nevro at the conference?

D. Keith Grossman, the Chairman, CEO, and President of Nevro, will represent the company.

Where is the J.P. Morgan Healthcare Conference being held?

The conference will take place at the Westin St. Francis Hotel in San Francisco, CA.

How can investors access Nevro's conference presentation?

Investors can access a live webcast of the presentation on Nevro's website.

What is the focus of Nevro Corp.?

Nevro Corp. specializes in innovative medical devices for chronic pain treatment, specifically the Senza spinal cord stimulation system.

NEVRO CORP.

NYSE:NVRO

NVRO Rankings

NVRO Latest News

NVRO Stock Data

216.24M
37.28M
3.73%
96.48%
8.4%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
REDWOOD CITY